Search bioRxiv⌕ Search

bioRxiv · 10.1101/2025.09.09.674997

Facial Micro-Movements as a Proxy of Increasingly Erratic Heart Rate Variability While Experiencing Pressure Pain

Abstract

The sensation of pain varies from person to person. These patterns of individual variations are difficult to capture using coarse subjective self-reports. However, they are important when prescribing therapies and tailoring them to the persons own sensations. Pain can be experienced differently by the same person, and fluctuate differently depending on the context, yet most analyses treat the problem under a one-size-fits-all model. In this work, we introduce a series of assays to objectively assess pressure pain across tasks with different motoric and cognitive demands, in relation to resting state. In a cohort of healthy individuals, we examine pain-free vs. pain states at rest, during drawing with heavy cognitive demands, during pointing to a visual target, and during a grooved peg task like inserting a grooved key in a matching grooved keyhole. We recorded Face videos, electrocardiographic signals and adopt a standardized data type called the micro-movement spikes (MMS) to characterize the biorhythmic activities of the Face micro-expressions and of the micro-fluctuations in the hearts inter beat interval timings. Using the MMS peaks, we find that the continuous Gamma family of probability distribution functions best fit the frequency histograms of both the Face and the heart data. Further, we find that the Gamma shape and scale parameters in both signals span a scaling power law whereby as the noise- to-signal ratio (Gamma scale parameter) increases, so does the randomness of the stochastic process (the Gamma shape decreases towards the memoryless exponential range). We find that as the heart IBI turns more erratic (noisier and more random) the facial ophthalmic region increases the noise and randomness too, with higher linear correlation for tasks requiring haptic feedback (R2 0.84) than for tasks requiring higher cognitive and memory loads (R2 0.77). Increases in transfer entropy shows that recent past activity ([~]167ms back) of the heart IBI and Face combined lower the uncertainty in the prediction of the present ophthalmic-Face activity, suggesting that this Face region may serve as a proxy of an increasingly dysregulated heart. These results bear implications for the detection and monitoring of pressure pain and heart dysregulated states. Scope StatementThis work uncovers personalized thresholds of pain through the combination of the participants fluctuations in HRV and facial micro-expressions. These signals are obtained before and after experiencing the sensation of pressure pain compared to a pain-free control condition. Tasks with higher haptic demand evoke higher differentiation in the signals than tasks with higher cognitive and memory loads. As the detection and tracking of such individual thresholds is possible through these unobtrusive and highly scalable methods, the work has implications for the personalized tailoring of pain treatments beyond the realms of the lab.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Torres, E. B., Elsayed, M.. 2025-09-10. Facial Micro-Movements as a Proxy of Increasingly Erratic Heart Rate Variability While Experiencing Pressure Pain. https://doi.org/10.1101/2025.09.09.674997

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗